Search Results for: SMAD2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel SLC6A4 solute carrier family 6 member 4
  • Serotonin clearance from the synaptic cleft
  • SLC-mediated transport of neurotransmitters
  • Fluvoxamine
  • Amphetamine
  • Phentermine
  • Tramadol
  • Citalopram
  • Benzatropine
  • Venlafaxine
  • Atomoxetine
  • Amitriptyline
  • Protriptyline
  • Loxapine
  • Meperidine
  • Imipramine
  • Fluoxetine
  • Duloxetine
  • Dextromethorphan
  • Nortriptyline
  • Amoxapine
  • Fenfluramine
  • Mazindol
  • Trazodone
  • Verapamil
  • Paroxetine
  • Trimipramine
  • Minaprine
  • Pseudoephedrine
  • Cocaine
  • Cyclobenzaprine
  • Dopamine
  • Sertraline
  • Sibutramine
  • Chlorpheniramine
  • Doxepin
  • Nefazodone
  • Desipramine
  • Escitalopram
  • Dexfenfluramine
  • Aripiprazole
  • Clomipramine
  • Ephedra sinica root
  • MMDA
  • Midomafetamine
  • 4-Methoxyamphetamine
  • Metamfetamine
  • Nomifensine
  • Zimelidine
  • Amineptine
  • Bicifadine
  • Milnacipran
  • OPC-14523
  • CRx-119
  • Amitifadine
  • Lumateperone
  • Mianserin
  • Tesofensine
  • Tapentadol
  • Vilazodone
  • Desvenlafaxine
  • Dexmethylphenidate
  • Serotonin
  • Levomilnacipran
  • Butriptyline
  • Vortioxetine
  • Dosulepin
  • Nisoxetine
  • Lorpiprazole
  • Zotepine
  • Dasotraline
Novel TCF4 transcription factor 4
  • Myogenesis
  • Myogenesis
  • TGFBR3 expression
  • Pitt-Hopkins syndrome, including: Pitt-Hopkins syndrome; Pitt-Hopkins-like syndrome
ABTB1 ankyrin repeat and BTB domain containing 1
ACVR1B activin A receptor type 1B
  • Signaling by NODAL
  • Regulation of signaling by NODAL
  • Signaling by Activin
  • ATP
  • Fostamatinib
AFDN afadin, adherens junction formation factor
  • (5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one
AKT1 AKT serine/threonine kinase 1
  • Activation of BAD and translocation to mitochondria
  • PIP3 activates AKT signaling
  • PIP3 activates AKT signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • MTOR signalling
  • AKT phosphorylates targets in the cytosol
  • AKT phosphorylates targets in the cytosol
  • AKT phosphorylates targets in the nucleus
  • Negative regulation of the PI3K/AKT network
  • eNOS activation
  • AKT-mediated inactivation of FOXO1A
  • Integrin signaling
  • Deactivation of the beta-catenin transactivating complex
  • CD28 dependent PI3K/Akt signaling
  • Co-inhibition by CTLA4
  • G beta:gamma signalling through PI3Kgamma
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • KSRP (KHSRP) binds and destabilizes mRNA
  • VEGFR2 mediated vascular permeability
  • TP53 Regulates Metabolic Genes
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Interleukin-4 and Interleukin-13 signaling
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
  • RAB GEFs exchange GTP for GDP on RABs
  • RUNX2 regulates genes involved in cell migration
  • Regulation of PTEN stability and activity
  • Extra-nuclear estrogen signaling
  • Negative regulation of NOTCH4 signaling
  • FLT3 Signaling
  • Regulation of localization of FOXO transcription factors
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • KEAP1-NFE2L2 pathway
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Mitochondrial unfolded protein response (UPRmt)
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
  • ATP
  • Arsenic trioxide
  • Genistein
  • Inositol 1,3,4,5-Tetrakisphosphate
  • Resveratrol
  • Archexin
  • Enzastaurin
  • Perifosine
  • N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
  • PTEN hamartoma tumor syndrome (PHTS), including: Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Proteus syndrome; Proteus-like syndrome
ANAPC10 anaphase promoting complex subunit 10
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • APC/C:Cdc20 mediated degradation of Securin
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Cdc20:Phospho-APC/C mediated degradation of Cyclin A
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Regulation of APC/C activators between G1/S and early anaphase
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Phosphorylation of the APC/C
  • APC-Cdc20 mediated degradation of Nek2A
  • Separation of Sister Chromatids
  • Senescence-Associated Secretory Phenotype (SASP)
  • Assembly of the pre-replicative complex
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional Regulation by VENTX
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Antigen processing: Ubiquitination & Proteasome degradation
ANAPC2 anaphase promoting complex subunit 2
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • APC/C:Cdc20 mediated degradation of Securin
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Cdc20:Phospho-APC/C mediated degradation of Cyclin A
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Regulation of APC/C activators between G1/S and early anaphase
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Phosphorylation of the APC/C
  • APC-Cdc20 mediated degradation of Nek2A
  • Separation of Sister Chromatids
  • Senescence-Associated Secretory Phenotype (SASP)
  • Assembly of the pre-replicative complex
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional Regulation by VENTX
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Antigen processing: Ubiquitination & Proteasome degradation
ANK3 ankyrin 3
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • COPI-mediated anterograde transport
  • Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
ANP32B acidic nuclear phosphoprotein 32 family member B
ANP32E acidic nuclear phosphoprotein 32 family member E
ANTXR2 ANTXR cell adhesion molecule 2
  • MDX-1303
  • Infantile systemic hyalinosis and juvenile hyaline fibromatosis
AP1B1 adaptor related protein complex 1 subunit beta 1
  • Nef mediated downregulation of MHC class I complex cell surface expression
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
ARFGAP3 ARF GTPase activating protein 3
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • CDC42 GTPase cycle
  • RHOG GTPase cycle
ARHGEF6 Rac/Cdc42 guanine nucleotide exchange factor 6
  • NRAGE signals death through JNK
  • G alpha (12/13) signalling events
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
  • G beta:gamma signalling through CDC42
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RHOU GTPase cycle
  • Non-syndromic X-linked mental retardation
ARL4D ARF like GTPase 4D
ATP5ME ATP synthase membrane subunit e
  • Formation of ATP by chemiosmotic coupling
  • Cristae formation
  • Phenethyl Isothiocyanate
AXIN1 axin 1
  • Degradation of beta-catenin by the destruction complex
  • Beta-catenin phosphorylation cascade
  • TCF dependent signaling in response to WNT
  • Degradation of AXIN
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Signaling by GSK3beta mutants
  • CTNNB1 S33 mutants aren't phosphorylated
  • CTNNB1 S37 mutants aren't phosphorylated
  • CTNNB1 S45 mutants aren't phosphorylated
  • CTNNB1 T41 mutants aren't phosphorylated
  • APC truncation mutants have impaired AXIN binding
  • AXIN missense mutants destabilize the destruction complex
  • Truncations of AMER1 destabilize the destruction complex
  • Ub-specific processing proteases
  • RUNX1 regulates estrogen receptor mediated transcription
  • RUNX1 regulates transcription of genes involved in WNT signaling
  • Estrogen-dependent gene expression
  • 1,4-Dithiothreitol
  • Caudal duplication anomaly
  • Hepatocellular carcinoma
BAZ1A bromodomain adjacent to zinc finger domain 1A
BECN1 beclin 1
  • ISG15 antiviral mechanism
  • Macroautophagy
  • Ub-specific processing proteases
  • Translation of Replicase and Assembly of the Replication Transcription Complex
  • Translation of Replicase and Assembly of the Replication Transcription Complex
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • RSV-host interactions
  • Estradiol
  • Estradiol acetate
  • Estradiol benzoate
  • Estradiol cypionate
  • Estradiol dienanthate
  • Estradiol valerate

Page 1 out of 12 pages